Grifols SA
GRFS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001438569
No open-market purchases or sales by Grifols SA insiders were filed in the last 90 days; 164 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Grifols SA changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 129 | 1 | 150 | +22 |
| Shares | 144.7M | 2.28M | 139.6M | −2.76M (−1.9%) |
| Value | $912.2M | $14.4M | $1.24B | +$342.5M (+38.1%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (33)
Institutions that held Grifols SA at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (11)
Institutions that held Grifols SA at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Flat Footed LLC | 8,976,421 | $56.6M |
| T. Rowe Price Investment Management, Inc. | 1,303,596 | $8.21M |
| Group One Trading, L.P. | 230,735 | $1.45M |
| Amundi | 62,712 | $416.4K |
| Ramirez Asset Management, Inc. | 52,374 | $330.2K |
| Capstone Investment Advisors, LLC | 31,520 | $198.7K |
| Mint Tower Capital Management B.V. | 22,465 | $142.0K |
| Deutsche Bank AG | 19,617 | $123.8K |
| Huntington National Bank | 10,000 | $63.0K |
| Glenmede Trust Co NA | 6,874 | $43.3K |
| Family Firm, Inc. | 35 | $221 |
Not filed for Q3 2024 yet (1)
Institutions that held Grifols SA at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 2,277,896 | $14.4M |